Andrés Cervantes is Professor of Medicine at the University of Valencia and serves as Head of Section at the Dept. of Hematology and Medical Oncology in the Biomedical Research Institute INCLIVA. He got the Medical Oncology degree at the same institution in 1985. After completing his clinical training, he got a research fellowship at the Free University Hospital in Amsterdam, where he obtained in 1987 his PhD degree with a work on multidrug resistance in the Cellular Pharmacology Lab of this institution. His main areas of research are gastrointestinal and gynaecologic malignancies, phase I trials and new drug development. He has authored many research articles and educational papers published in peer-reviewed journals. He is also the Editor of Cancer Treatment Reviews. He is currently member of the ESMO Executive, as well as of the Educational Steering Committee. He is chairing the Clinical Practice Guidelines Working Group at ESMO. He devotes a significant amount of time to teaching, professional training, and continuing medical education.